Radiopharm Theranostics (RAD:AU) has announced RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202 Download the PDF here. This post appeared first on investingnews.com Prev Post Tesla’s robotaxi launch in tech-friendly Austin has Musk playing catch-up in his hometown June 4, 2025 Next Post S&P 500 Bullish Patterns: Are Higher Highs Ahead? June 4, 2025 Related Posts Trump Admin Strips “Safety” from AI Oversight Institute in Move to Rebrand June 6, 2025 In-fill RC Drilling at Kamperman Confirms High-Grade Gold June 6, 2025 Offer Booklet – Non-Renounceable Entitlement Offer June 6, 2025